Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: A phase III double-blind crossover study (N01CB)

Supportive Care in Cancer

Volumn 17, Issue 4, 2009, Pages 451-460

  Cheville, Andrea L ^a   Sloan, Jeff A ^a   Northfelt, Donald W ^b   Jillella, Anand P ^c   Wong, Gilbert Y ^a   Bearden Iii, James D ^d   Liu, Heshan ^a   Schaefer, Paul L ^e   Marchello, Benjamin T ^f   Christensen, Bradley J ^a   Loprinzi, Charles L ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d Upstate Carolina CCOP   (United States)

^e Toledo Community Hospital Oncology Program   (United States)

^f Montana Cancer Consortium   (United States)

Author keywords

Cancer; Cancer related pain; Lidocaine patch; Postsurgical neuropathic pain

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; DEXTROPROPOXYPHENE; HYDROCODONE; IBUPROFEN; LIDOCAINE; NAPROXEN; OXYCODONE; PARACETAMOL; PLACEBO; ROFECOXIB;

ADULT; AGED; ARTICLE; BRIEF PAIN INVENTORY; CANCER PAIN; CANCER PATIENT; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DESQUAMATION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; FATIGUE; FEMALE; HUMAN; HYPERSENSITIVITY; MALE; MOTOR DYSFUNCTION; MULTICENTER STUDY; NEUROPATHIC PAIN; PAIN ASSESSMENT; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RATING SCALE; THORAX PAIN;

ADMINISTRATION, CUTANEOUS; AGED; ANESTHETICS, LOCAL; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIDOCAINE; MALE; MIDDLE AGED; NEOPLASMS; NEURALGIA; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; TREATMENT OUTCOME;

EID: 62449230557     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-008-0542-x     Document Type: Article

References (43)

1. CE Argoff 2004 Conclusions: chronic pain studies of lidocaine patch 5% using the Neuropathic Pain Scale Curr Med Res Opin 20 Suppl 2 S29 S31 doi:10.1185/030079904X12979
2. F Baker M Denniston J Zabora A Polland WN Dudley 2002 A POMS short form for cancer patients: psychometric and structural evaluation Psychooncology 11 273 281 doi:10.1002/pon.564
3. C Begg M Cho S Eastwood R Horton D Moher I Olkin R Pitkin D Rennie KF Schulz D Simel DF Stroup 1996 Improving the quality of reporting of randomized controlled trials. The CONSORT statement JAMA 276 637 639 doi:10.1001/jama.276. 8.637
4. JN Campbell SN Raja RA Meyer SE Mackinnon 1988 Myelinated afferents signal the hyperalgesia associated with nerve injury Pain 32 89 94 doi:10.1016/0304-3959(88)90027-9
5. C Cleeland 1992
6. TJ Coderre J Katz AL Vaccarino R Melzack 1993 Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence Pain 52 259 285 doi:10.1016/0304-3959(93)90161-H
7. E Dajczman A Gordon H Kreisman N Wolkove 1991 Long-term postthoracotomy pain Chest 99 270 274 doi:10.1378/chest.99.2.270
8. RH Dworkin AE Corbin JP Young Jr U Sharma L LaMoreaux H Bockbrader EA Garofalo RM Poole 2003 Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial Neurology 60 1274 1283
9. DPH Fairclough D Cella P Bonomi 1998 Comparison of several model-based methods for analyzing incomplete quality of life data in cancer trials Stat Med 17 781 796
10. JT Farrar JP Young Jr L LaMoreaux JL Werth RM Poole 2001 Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale Pain 94 149 158 doi:10.1016/S0304-3959(01)00349-9
11. BS Galer MC Rowbotham J Perander E Friedman 1999 Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study Pain 80 533 538 doi:10.1016/S0304- 3959(98)00244-9
12. BS Galer MP Jensen T Ma PS Davies MC Rowbotham 2002 The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale Clin J Pain 18 297 301 doi:10.1097/00002508-200209000- 00004
13. AR Gammaitoni NA Alvarez BS Galer 2003 Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature J Clin Pharmacol 43 111 117 doi:10.1177/0091270002239817
14. C Hurny J Bernhard A Coates HF Peterson M Castiglione-Gertsch RD Gelber CM Rudenstam J Collins J Lindtner A Goldhirsch HJ Senn 1996 Responsiveness of a single-item indicator versus a multi-item scale: assessment of emotional well-being in an international adjuvant breast cancer trial Med Care 34 234 248 doi:10.1097/00005650-199603000-00004
15. MP Jensen P Karoly S Braver 1986 The measurement of clinical pain intensity: a comparison of six methods Pain 27 117 126 doi:10.1016/0304-3959(86) 90228-9
16. MP Jensen RH Dworkin AR Gammaitoni DO Olaleye N Oleka BS Galer 2005 Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain Scale J Pain 6 98 106 doi:10.1016/j.jpain.2004. 11.002
17. A Johansson J Kornfalt L Nordin L Svensson C Ingvar J Lundberg 2003 Wound infiltration with ropivacaine and fentanyl: effects on postoperative pain and PONV after breast surgery J Clin Anesth 15 113 118 doi:10.1016/S0952-8180(02) 00511-1
18. MK Karmakar AM Ho 2004 Postthoracotomy pain syndrome Thorac Surg Clin 14 345 352 doi:10.1016/S1547-4127(04)00022-2
19. J Katz CJ McCartney 2002 Current status of pre-emptive analgesia Curr Opin Anaesthesiol 15 435 441 doi:10.1097/00001503-200208000-00005
20. H Kehlet TS Jensen CJ Woolf 2006 Persistent postsurgical pain: risk factors and prevention Lancet 367 1618 1625 doi:10.1016/S0140-6736(06)68700-X
21. CL Loprinzi JW Kugler JA Sloan TW Rooke SK Quella P Novotny RB Mowat JC Michalak PJ Stella R Levitt LK Tschetter H Windschitl 1999 Lack of effect of coumarin in women with lymphedema after treatment for breast cancer N Engl J Med 340 346 350 doi:10.1056/NEJM199902043400503
22. D Lussier AG Huskey RK Portenoy 2004 Adjuvant analgesics in cancer pain management Oncologist 9 571 591 doi:10.1634/theoncologist.9-5-571
23. L Macdonald J Bruce NW Scott WC Smith WA Chambers 2005 Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome Br J Cancer 92 225 230
24. RC Malenka 1991 The role of postsynaptic calcium in the induction of long-term potentiation Mol Neurobiol 5 289 295 doi:10.1007/BF02935552
25. Mandrekar JSD, Novotny PJ, Slaon JA (1999) A general Gibbs sampling algorithm for analyzing linear models using the SAS system. In: Proceedings of the SUGI, p 1644-1649
26. JSD Mandrekar PJ Novotny JA Slaon 1999 A general Gibbs sampling algorithm for analyzing linear models using the SAS system SUGI Proc 24 1644 1649
27. R Melzack 1975 The McGill Pain Questionnaire: major properties and scoring methods Pain 1 277 299 doi:10.1016/0304-3959(75)90044-5
28. R Melzack 1987 The short-form McGill pain questionnaire Pain 30 191 197 doi:10.1016/0304-3959(87)91074-8
29. A Nguyen F Girard D Boudreault F Fugere M Ruel R Moumdjian A Bouthilier JL Caron MW Bojanowski DC Girard 2001 Scalp nerve blocks decrease the severity of pain after craniotomy Anesth Analg 93 1272 1276 doi:10.1097/00000539- 200111000-00048
30. A Osman FX Barrios BA Kopper W Hauptmann J Jones E O'Neill 1997 Factor structure, reliability, and validity of the Pain Catastrophizing Scale J Behav Med 20 589 605 doi:10.1023/A:1025570508954
31. J Pergolizzi RH Boger K Budd A Dahan S Erdine G Hans HG Kress R Langford R Likar RB Raffa P Sacerdote 2008 Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone) Pain Pract 8 287 313 doi:10.1111/j.1533-2500.2008.00204.x
32. SJ Pocock R Simon 1975 Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial Biometrics 31 103 115 doi:10.2307/2529712
33. SS Reuben 2007 Chronic pain after surgery: what can we do to prevent it Curr Pain Headache Rep 11 5 13 doi:10.1007/s11916-007-0015-9
34. MC Rowbotham PS Davies C Verkempinck BS Galer 1996 Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia Pain 65 39 44 doi:10.1016/0304-3959(95)00146-8
35. Senn S (1993) Cross-over trials in clinical research. Wiley, New York
36. JA Sloan A Dueck 2004 Issues for statisticians in conducting analyses and translating results for quality of life end points in clinical trials J Biopharm Stat 14 73 96 doi:10.1081/BIP-120028507
37. JANP Sloan CL Lorinzi S Nair 1997 Graphical and analytical tools for the analysis two-period crossover clinical trials SUGI Proc 22 1312 1317
38. Sloan JA OFJ, Suman VJ, Sargeant DJ (1998) Incorporating quality of life measurement in oncology clinical trials. In: Proceedings of the American Statistical Association, p 281-287
39. MS Wallace AM Wallace J Lee MK Dobke 1996 Pain after breast surgery: a survey of 282 women Pain 66 195 205 doi:10.1016/0304-3959(96)03064-3
40. Wiffen PJ, McQuay HJ, Edwards JE, Moore RA (2005) Gabapentin for acute and chronic pain. Cochrane Database Syst Rev CD005452
41. Wiffen PJ, McQuay HJ, Moore RA (2005) Carbamazepine for acute and chronic pain. Cochrane Database Syst Rev CD005451
42. CJ Woolf MW Salter 2000 Neuronal plasticity: increasing the gain in pain Science 288 1765 1769 doi:10.1126/science.288.5472.1765
43. TL Yaksh 2006 Calcium channels as therapeutic targets in neuropathic pain J Pain 7 S13 S30 doi:10.1016/j.jpain.2005.09.007